Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples